Comparison of Resected vs. Non-resected PanCO Study Patients with Unresectable Locally Advanced Pancreatic Cancer (uLAPC) Receiving 32P-microparticles and Chemotherapy
HPB(2023)
摘要
Introduction: uLAPC has poor prognosis. We report post-hoc analysis of resected vs. non-resected cohorts in a study of beta-radiation-emitting Phosphorous-32 (32P)-microparticles, implanted into tumours via endoscopic-ultrasound (EUS) guidance, and standard-of-care chemotherapy in uLAPC.
更多查看译文
关键词
pancreatic cancer,chemotherapy,ulapc,non-resected,p-microparticles
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要